0.1688
900 319 0030
x

India US - Import Alert

iasparliament Logo
March 28, 2017

Why in news?

The stock of Divi’s Laboratories dropped over 20% following the announcement that one its facility has received an import alert from the US drug regulator U S Food and Drug Administration (FDA).

What is import alert?

  • Companies that sell medicines in the US market are required to comply with the regulations mandated by the FDA.
  • Manufacturing units that supply drugs to the US are inspected by the FDA periodically.
  • If they find any lapses in the adherence to the mandated regulations, the same is notified by the FDA in Form 483 as observations.
  • This is the first level of action by the FDA in case of deviation from the good manufacturing practices (GMP).
  • The company is given time to respond to the observations.
  • If the reply is not convincing the FDA may issue a warning letter.
  • This letter restricts the ability of that manufacturing unit to supply drugs to the US from that facility.
  • Then the company has to appoint consultants to advice on corrective actions and its monitor implementation.
  • After this, it approaches the FDA for re-inspection.
  • If the FDA is not satisfied again, it issues an import alert.
  • This implies a ban on the facility from supplying drugs to the US.
  • However, there have been instances where the FDA has directly issued an import alert even without an initial warning letter.

Why is it important?

  • The US is the largest pharmaceutical market in the world.
  • The share of Indian pharma companies in the US market has risen significantly over the past few years, catering nearly 40% of its pharma drug requirement.
  • Many patents are expected to expire in the upcoming years, opening a huge market for generic drugs from India.
  • So to an investor in pharma stocks, it is important to keep a close tab on the regulatory action by the FDA as they can pose growth risks.
  • The progression of observations into import alerts and warning letters has been increasing of late.
  • So investors need to focus on the speed with which a company resolves these issues.

 

Source: Business Line

Login or Register to Post Comments
There are no reviews yet. Be the first one to review.

ARCHIVES

MONTH/YEARWISE ARCHIVES

Free UPSC Interview Guidance Programme